Cedar Brook Financial Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,051
| Closed | -$738K | – | 30 |
|
|
2024
Q1 | $738K | Buy |
4,051
+613
| +18% | +$112K | 0.15% | 160 |
|
|
2023
Q4 | $563K | Buy |
3,438
+119
| +4% | +$19.5K | 0.13% | 177 |
|
|
2023
Q3 | $495K | Sell |
3,319
-339
| -9% | -$50.5K | 0.13% | 175 |
|
|
2023
Q2 | $493K | Sell |
3,658
-63
| -2% | -$8.49K | 0.12% | 184 |
|
|
2023
Q1 | $593K | Buy |
3,721
+402
| +12% | +$64.1K | 0.15% | 154 |
|
|
2022
Q4 | $536K | Sell |
3,319
-72
| -2% | -$11.6K | 0.15% | 161 |
|
|
2022
Q3 | $455K | Buy |
3,391
+455
| +15% | +$61.1K | 0.15% | 176 |
|
|
2022
Q2 | $450K | Buy |
2,936
+129
| +5% | +$19.8K | 0.14% | 177 |
|
|
2022
Q1 | $455K | Buy |
2,807
+638
| +29% | +$103K | 0.12% | 199 |
|
|
2021
Q4 | $294K | Buy |
+2,169
| New | +$294K | 0.08% | 284 |
|
|
2021
Q3 | – | Sell |
-2,043
| Closed | -$230K | – | 347 |
|
|
2021
Q2 | $230K | Buy |
+2,043
| New | +$230K | 0.07% | 330 |
|
|
2021
Q1 | – | Sell |
-1,997
| Closed | -$214K | – | 319 |
|
|
2020
Q4 | $214K | Buy |
+1,997
| New | +$214K | 0.08% | 290 |
|
|
2020
Q3 | – | Sell |
-2,172
| Closed | -$213K | – | 294 |
|
|
2020
Q2 | $213K | Buy |
+2,172
| New | +$213K | 0.09% | 245 |
|